Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Metabolic Dysfunction-Associated Steatotic Liver Disease

Interventions

DIETARY_SUPPLEMENT

Probiotics

1 capsule(with three different dosage) per day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

1 capsule per day for 12weeks

Trial Locations (1)

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER